epirubicin has been researched along with Hypercalcemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuvertoret-Sanz, M; Marco, A; MartÃnez, J; MartÃnez-Sogues, L; Novellas, R; Pastor, J; Roura, X; Solano-Gallego, L; Vila, A | 1 |
| Hassali, MA; Hassan, BA; Othman, SB; Weiderpass, E; Yusoff, ZB | 1 |
2 other study(ies) available for epirubicin and Hypercalcemia
| Article | Year |
|---|---|
Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Dog Diseases; Dogs; Epirubicin; Hypercalcemia; Male; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Prednisone | 2019 |
Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Deoxycytidine; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Hypercalcemia; Imidazoles; Linear Models; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pamidronate; Parathyroid Hormone-Related Protein; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Taxoids; Young Adult; Zoledronic Acid | 2012 |